Literature DB >> 16436439

Comparative analysis of antibiotic resistance gene markers in Mycoplasma genitalium: application to studies of the minimal gene complement.

Oscar Q Pich1, Raul Burgos1, Raquel Planell1, Enrique Querol1, Jaume Piñol1.   

Abstract

Mycoplasma genitalium has been proposed as a suitable model for an in-depth understanding of the biology of a free-living organism. This paper reports that the expression of the aminoglycoside resistance gene aac(6')-aph(2''), the only selectable marker hitherto available for M. genitalium genetic studies, correlates with a growth impairment of the resistant strains. In light of this finding, a tetM438 construction based on the tetracycline resistance gene tetM was developed; it can be used efficiently in M. genitalium and confers multiple advantages when compared to aac(6')-aph(2''). The use of tetM438 significantly improves transformation efficiency and generates visible colonies faster. Finally, the improvements in the pMTnTetM438 construction made it possible to obtain insertions in genes which have not been previously considered to be dispensable under laboratory growth conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16436439     DOI: 10.1099/mic.0.28287-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  29 in total

1.  Expression and characterization of a Mycoplasma genitalium glycosyltransferase in membrane glycolipid biosynthesis: potential target against mycoplasma infections.

Authors:  Eduardo Andrés; Núria Martínez; Antoni Planas
Journal:  J Biol Chem       Date:  2011-08-11       Impact factor: 5.157

2.  Functional analysis of the Mycoplasma genitalium MG312 protein reveals a specific requirement of the MG312 N-terminal domain for gliding motility.

Authors:  Raul Burgos; Oscar Q Pich; Enrique Querol; Jaume Piñol
Journal:  J Bacteriol       Date:  2007-08-03       Impact factor: 3.490

3.  Localization of P42 and F(1)-ATPase α-subunit homolog of the gliding machinery in Mycoplasma mobile revealed by newly developed gene manipulation and fluorescent protein tagging.

Authors:  Isil Tulum; Masaru Yabe; Atsuko Uenoyama; Makoto Miyata
Journal:  J Bacteriol       Date:  2014-02-07       Impact factor: 3.490

4.  Mycoplasma genitalium P140 and P110 cytadhesins are reciprocally stabilized and required for cell adhesion and terminal-organelle development.

Authors:  Raul Burgos; Oscar Q Pich; Mario Ferrer-Navarro; Joel B Baseman; Enrique Querol; Jaume Piñol
Journal:  J Bacteriol       Date:  2006-10-06       Impact factor: 3.490

5.  RecA mediates MgpB and MgpC phase and antigenic variation in Mycoplasma genitalium, but plays a minor role in DNA repair.

Authors:  Raul Burgos; Gwendolyn E Wood; Lei Young; John I Glass; Patricia A Totten
Journal:  Mol Microbiol       Date:  2012-07-05       Impact factor: 3.501

6.  MG428 is a novel positive regulator of recombination that triggers mgpB and mgpC gene variation in Mycoplasma genitalium.

Authors:  Raul Burgos; Patricia A Totten
Journal:  Mol Microbiol       Date:  2014-09-05       Impact factor: 3.501

7.  Mycoplasma genitalium Nonadherent Phase Variants Arise by Multiple Mechanisms and Escape Antibody-Dependent Growth Inhibition.

Authors:  Raul Burgos; Gwendolyn E Wood; Stefanie L Iverson-Cabral; Patricia A Totten
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

8.  Transcriptional regulation of MG_149, an osmoinducible lipoprotein gene from Mycoplasma genitalium.

Authors:  Wenbo Zhang; Joel B Baseman
Journal:  Mol Microbiol       Date:  2011-06-22       Impact factor: 3.501

9.  Functional characterization of osmotically inducible protein C (MG_427) from Mycoplasma genitalium.

Authors:  Wenbo Zhang; Joel B Baseman
Journal:  J Bacteriol       Date:  2013-12-20       Impact factor: 3.490

10.  P110 and P140 cytadherence-related proteins are negative effectors of terminal organelle duplication in Mycoplasma genitalium.

Authors:  Oscar Q Pich; Raul Burgos; Enrique Querol; Jaume Piñol
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.